Page last updated: 2024-10-17

phosphonoacetic acid and Acute Kidney Injury

phosphonoacetic acid has been researched along with Acute Kidney Injury in 4 studies

Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.

Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Research Excerpts

ExcerptRelevanceReference
"Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients."7.68Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991)
"Foscarnet is an investigational antiviral agent that has been used effectively in the treatment of cytomegalovirus (CMV) retinitis in AIDS patients."3.68Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. ( Gambertoglio, JG; Graziani, AL; Grunwald, JE; MacGregor, RR; Weiss, R, 1991)
"Foscarnet is a pyrophosphate analogue that has been successfully used in severe cytomegalovirus (CMV) infections."1.28Foscarnet nephrotoxicity: mechanism, incidence and prevention. ( Baumelou, A; Beaufils, H; Danis, M; Deray, G; Dohin, E; Gentilini, M; Katlama, C; Levaltier, B; Martinez, F; Rozenheim, M, 1989)
"Foscarnet (FC) is a new antiviral agent which has been recently proposed for the treatment of severe cytomegalovirus (CMV) infections in immunocompromised patients."1.27Acute renal failure induced by foscarnet: 4 cases. ( Baumelou, A; Cacoub, P; Deray, G; Gentilini, M; Jacobs, C; Le Hoang, P; Rousselie, R; Rozenbaum, W; Soubrie, C, 1988)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacGregor, RR1
Graziani, AL1
Weiss, R1
Grunwald, JE1
Gambertoglio, JG1
Deray, G3
Martinez, F1
Katlama, C1
Levaltier, B1
Beaufils, H1
Danis, M1
Rozenheim, M1
Baumelou, A3
Dohin, E1
Gentilini, M2
Cacoub, P2
Le Hoang, P2
Rozenbaum, W1
Soubrie, C2
Rousselie, R1
Jacobs, C2
Rousselie, F1
Morer, I1

Other Studies

4 other studies available for phosphonoacetic acid and Acute Kidney Injury

ArticleYear
Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.
    The Journal of infectious diseases, 1991, Volume: 164, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Cytomegalovirus In

1991
Foscarnet nephrotoxicity: mechanism, incidence and prevention.
    American journal of nephrology, 1989, Volume: 9, Issue:4

    Topics: Acute Kidney Injury; Adult; Aged; Cohort Studies; Creatinine; Cytomegalovirus Infections; Fluid Ther

1989
Acute renal failure induced by foscarnet: 4 cases.
    Clinical nephrology, 1988, Volume: 29, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Antiviral Agents; Chorioretinitis; C

1988
Foscarnet-induced acute renal failure and effectiveness of haemodialysis.
    Lancet (London, England), 1987, Jul-25, Volume: 2, Issue:8552

    Topics: Acute Kidney Injury; Female; Foscarnet; Humans; Middle Aged; Organophosphorus Compounds; Phosphonoac

1987